NO20005286L - Behandling av generelle angstforstyrrelser med paroxetin - Google Patents

Behandling av generelle angstforstyrrelser med paroxetin

Info

Publication number
NO20005286L
NO20005286L NO20005286A NO20005286A NO20005286L NO 20005286 L NO20005286 L NO 20005286L NO 20005286 A NO20005286 A NO 20005286A NO 20005286 A NO20005286 A NO 20005286A NO 20005286 L NO20005286 L NO 20005286L
Authority
NO
Norway
Prior art keywords
paroxetine
treatment
anxiety disorders
general anxiety
general
Prior art date
Application number
NO20005286A
Other languages
English (en)
Other versions
NO20005286D0 (no
Inventor
Rocco Zaninelli
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of NO20005286D0 publication Critical patent/NO20005286D0/no
Publication of NO20005286L publication Critical patent/NO20005286L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20005286A 1998-04-22 2000-10-20 Behandling av generelle angstforstyrrelser med paroxetin NO20005286L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9808479.1A GB9808479D0 (en) 1998-04-22 1998-04-22 Method of treatment
PCT/US1999/008786 WO1999053919A1 (en) 1998-04-22 1999-04-22 Treatment of generalized anxiety disorder with paroxetine

Publications (2)

Publication Number Publication Date
NO20005286D0 NO20005286D0 (no) 2000-10-20
NO20005286L true NO20005286L (no) 2000-12-20

Family

ID=10830715

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20005286A NO20005286L (no) 1998-04-22 2000-10-20 Behandling av generelle angstforstyrrelser med paroxetin

Country Status (20)

Country Link
EP (1) EP1073437A4 (no)
JP (1) JP2002512189A (no)
KR (1) KR20010034817A (no)
CN (1) CN1298301A (no)
AP (1) AP2000001959A0 (no)
AU (1) AU3864899A (no)
BG (1) BG104939A (no)
BR (1) BR9909791A (no)
CA (1) CA2328896A1 (no)
CZ (1) CZ20003885A3 (no)
EA (1) EA200001088A1 (no)
GB (1) GB9808479D0 (no)
HU (1) HUP0101350A3 (no)
ID (1) ID27546A (no)
IL (1) IL139167A0 (no)
NO (1) NO20005286L (no)
PL (1) PL343494A1 (no)
SK (1) SK15672000A3 (no)
TR (1) TR200003082T2 (no)
WO (1) WO1999053919A1 (no)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2297550B (en) * 1995-02-06 1997-04-09 Smithkline Beecham Plc Paroxetine hydrochloride anhydrate substantially free of bound organic solvent
GB9514842D0 (en) * 1995-07-20 1995-09-20 Smithkline Beecham Plc Novel formulation

Also Published As

Publication number Publication date
AP2000001959A0 (en) 2000-12-31
HUP0101350A2 (hu) 2002-05-29
JP2002512189A (ja) 2002-04-23
WO1999053919A1 (en) 1999-10-28
IL139167A0 (en) 2001-11-25
SK15672000A3 (sk) 2001-04-09
CN1298301A (zh) 2001-06-06
CZ20003885A3 (cs) 2001-09-12
KR20010034817A (ko) 2001-04-25
PL343494A1 (en) 2001-08-27
TR200003082T2 (tr) 2001-01-22
BR9909791A (pt) 2000-12-26
BG104939A (bg) 2001-09-28
NO20005286D0 (no) 2000-10-20
ID27546A (id) 2001-04-12
GB9808479D0 (en) 1998-06-17
EP1073437A1 (en) 2001-02-07
EA200001088A1 (ru) 2001-04-23
EP1073437A4 (en) 2003-04-16
CA2328896A1 (en) 1999-10-28
AU3864899A (en) 1999-11-08
HUP0101350A3 (en) 2002-06-28

Similar Documents

Publication Publication Date Title
NO20021845D0 (no) Behandling av sövnforstyrrelser under anvendelse av desloratadin
NO993051L (no) Intranasale formuleringer for behandling av seksuelle forstyrrelser
NO20005884L (no) Kombinasjonsterapi for behandling av bipolare forstyrrelser
DE69936335D1 (de) Verwendung von morpholinol zur behandlung von sexuellen funktionsstörungen
NO20026263L (no) Sulfonyl-pyrrolidin-derivater anvendelige for behandling av neurologiske forstyrrelser
DE50014041D1 (de) Verwendung von epinastin zur behandlung von allergischer rhinitis/konjunktivitis
DE60022867D1 (de) 1-Arenesulfonyl-2-Aryl-Pyrrolidin und Piperidin Derivative zur Behandlung von CNS-Erkrankungen
NO20020062L (no) Behandling av nevrotiske forstyrrelser
ID27214A (id) Triazolopiridina untuk pengobatan gangguan trombosis
NO20032156L (no) Behandling av angstforstyrrelser
NO20010390D0 (no) Behandling av angstsykdommer
ATE292107T1 (de) Verwendung von carbonylaminoderivaten gegen zentralnervensystem-störungen
NO20023803D0 (no) Anvendelse av mirtazapin for behandling av sövnforstyrrelser
NO20003960D0 (no) Salter av paroksetin
ATE230741T1 (de) 3-tetrahydropyridin-4-yl-indole zur behandlung von psychotischen störungen
NO20006547D0 (no) Salter av paroxetine
NO20005216D0 (no) Sammensetning for behandling av eksterne sekresjonssykdommer unntatt hypolakrimasjon
NO20012612D0 (no) Isonipecotamider for behandling av integren-formidlede lidelser
EE200200670A (et) S-metüüldihüdroziprasidoon psühhiaatriliste ja silmahaiguste raviks
NO20005286L (no) Behandling av generelle angstforstyrrelser med paroxetin
NO20022244L (no) Behandling av SLE med dehydroepiandrosteron
NO20012538D0 (no) Anvendelse av N-substituerte azabicycloalkanderivater for behandling av forstyrrelser i sentralnervesystemet
DK82798A (da) Treatment of GABA-uptake related disorders

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application